TL;DR
Gestational breast cancer is potentially a clinically and molecularly different entity, with specific epidemiological, clinical, and histological features, as well as a distinctive altered immune state and genetic signature, and further studies are needed to better understand the biology of GBC.
AI-generated by Semantic Scholar
Authors
J. R. de la Haba-Rodríguez, P. Mínguez, F. Rojo, M. Martín, E. Alba, S. Servitja, A. Prat, J. A. Pérez-Fidalgo, J. Gavilá, C. Morales, A. Rodriguez-Lescure, C. Herrero, R Peña-Enriquez, J. Herranz, C. Hernando, A. Hernández-Blanquisett, S. Guil-Luna, MT. Martinez, S. Blanch, R. Caballero, N. Martín, M. Pollán, A. Guerrero-Zotano, B. Bermejo
